<DOC>
	<DOCNO>NCT00596063</DOCNO>
	<brief_summary>The purpose study comparative evaluation pharmacokinetics pharmacodynamics two recombinant regular human insulin injection administer subcutaneously healthy volunteer condition euglycemic clamp .</brief_summary>
	<brief_title>Comparative Glucose Clamp Study Wockhardt 's Insulin Human Regular Injection Novolin R , Healthy Subjects .</brief_title>
	<detailed_description>A comparative evaluation pharmacokinetics pharmacodynamics two recombinant regular human insulin injection administer subcutaneously healthy volunteer . It crossover study . The subject shall administer single dos insulin two separate visit condition euglycemic clamp .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>1 . Healthy male female subject . 2 . Age ≥ 18 ≤ 45 year . 3 . Body Mass Index ( BMI ) 18.0 27.0 kg/m2 , inclusive . 4 . Nonsmoker , define nicotine consumption least one year . 5 . Signed date informed consent obtain trialrelated activity . ( Trialrelated activity procedure would perform normal management subject. ) . 1 . Previous participation trial clinical trial within last 3 month . 2 . Pregnant , breastfeed intention become pregnant use adequate contraceptive measure ( intrauterine device ( IUD ) place least 3 month , sterilization , oral contraceptive pill , take without difficulty least 3 month , approve hormonal implant ) . 3 . Clinically significant abnormal hematology biochemistry screen test , judge Investigator . In particular , subject elevate liver enzymes ( AST ALT &gt; 2 time upper limit normal ) impair renal function ( elevate serum creatinine value upper limit normal ) allow enter trial . 4 . Any serious systemic infectious disease four week prior first dose test drug , judge Investigator . 5 . History illness , opinion Investigator , might confound result trial pose risk administer trial drug subject . In particular , subject significant cardiovascular disease , anemia ( haemoglobin low limit normal ) hemoglobinopathy allow enter trial . 6 . History alcohol drug abuse . 7 . Any positive reaction drug abuse . 8 . Hepatitis B C HIV positive . 9 . Use prescription drug within 3 week precede first dose insulin , except oral contraceptives/hormonal implant . 10 . Use insulin product therapeutic purpose past . 11 . Use nonprescription drug , except routine vitamin , within 3 week prior first dose test drug . Occasional use paracetamol permit . 12 . Mental incapacity , unwillingness language barrier preclude adequate understanding cooperation . 13 . Blood donation 500 ml within last 12 week . 14 . History multiple and/or severe allergy drug food history severe anaphylactic reaction . 15 . Known suspect allergy trial product relate product .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>pharmacokinetics</keyword>
	<keyword>pharmacodynamics</keyword>
	<keyword>recombinant human insulin</keyword>
	<keyword>healthy volunteer</keyword>
</DOC>